
Reata Pharmaceuticals
Biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Market cap
$6.6b
Enterprise value
$6.4b
Share price
$172.36 RETA
Authorizing premium user...
Biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.